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Background and aim: A high intake of whole grain foods is inversely associated with body mass index
(BMI) and body fat in observational studies, but mixed results have been found in interventional studies.
Among whole grains, rye is the richest source of dietary fiber and meals containing high-fiber rye foods
have shown increased satiety up to 8 h, compared to meals containing refined wheat products. The aim
of the study was to determine the effect of consuming high fiber rye products, compared to refined
wheat products, on body weight and body fat loss in the context of an energy restricted diet.
Methods: After a 2-week run-in period, 242 males and females with overweight or obesity (BMI 27
e35 kg/m2), aged 30e70 years, were randomized (1:1) to consume high fiber rye products or refined
wheat products for 12 weeks, while adhering to a hypocaloric diet. At week 0, week 6 and week 12 body
weight and body composition (dual energy x-ray absorptiometry) was measured and fasting blood
samples were collected. Subjective appetite was evaluated for 14 h at week 0, 6 and 12.
Results: After 12 weeks the participants in the rye group had lost 1.08 kg body weight and 0.54% body fat
more than the wheat group (95% confidence interval (CI): 0.36; 1.80, p < 0.01 and 0.05; 1.03, p ¼ 0.03,
respectively). C-reactive protein was 28% lower in the rye vs wheat group after 12 weeks of intervention
(CI: 7; 53, p < 0.01). There were no consistent group differences on subjective appetite or on other
cardiometabolic risk markers.
Conclusion: Consumption of high fiber rye products as part of a hypocaloric diet for 12 weeks caused a
greater weight loss and body fat loss, as well as reduction in C-reactive protein, compared to refined
wheat. The difference in weight loss could not be linked to differences in appetite response.
Clinical trial registration: www.clinicaltrials.gov, Identifier: NCT03097237.
© 2021 The Author(s). Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and
Metabolism. This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).; AR, alkylresorcinol; AUC, area under the curve; CRP, C-reactive protein; DXA, dual-energy x-ray absorptiometry; ITT,
rd; NNR, Nordic Nutrition Recommendations; SWAP, Step-wise Weight-determined Accumulative Change Plan; TFEQ,
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One of the most important health challenges of today is to
reduce the prevalence of non-communicable diseases which
together cause over 60% of total themortality globally [1]. Obesity is
a key risk factor for the development of non-communicable dis-
eases and lifestyle changes have driven obesity prevalence to
epidemic proportions [2,3]. Different types of lifestyle modifica-
tions that target this issue needs to be investigated [4]. Diet is one of
the major determinants for body weight changes and a key tool in
the prevention, management and treatment of overweight and
obesity [5].
A high whole grain intake is recommended by authorities in
many countries, including Sweden, where whole grain foods is
recommended whenever cereals are consumed [6]. A high whole
grain intake has been shown to have positive effects on several
health outcomes [7e9] including inverse association with body
mass index (BMI) and body fat in observational studies, but results
from intervention studies are inconsistent [10]. These discrepancies
might be explained by the fact that most of the studies reporting
the effect of wholegrain on body weight are not designed for
evaluation of the effect of whole grains on body weight loss.
Furthermore, whole grains from different cereals differ in many
aspects, such as fiber content and composition, and it is reasonable
to hypothesize that the health effects, including impact on body
weight and body composition, may vary accordingly [6,11].
Among cereals, rye which is commonly consumed in eastern
and Northern Europe, has the highest dietary fiber content and has
therefore been suggested to be superior to other whole grains in
terms of improving health related outcomes [11]. High fiber whole
grain rye food have been shown to increase satiety for up to 8 h
after consumption, compared to refined wheat products [12e16].
One hypothesis, which has been supported by a recent meta-
analysis, is that increased acute satiety could lead to reduced en-
ergy intake and in turn lead to weight loss [17]. Furthermore, rye
has been linked to a range of other beneficial health effects such as
reduced postprandial insulin [18], reductions in cholesterol [19,20]
and reductions in low-grade inflammation [20,21].
The aim of the present study, the RyeWeight study, was there-
fore to investigate whether a diet rich in high fiber whole grain rye
vs refinedwheat, as part of a hypocaloric diet, leads to larger weight
loss and larger reductions in body fat during a 12-week
intervention.
2. Subjects and methods
2.1. Study design and ethics statement
The RyeWeight study was designed as a parallel randomized
controlled study in free-living participants, aiming to compare the
effect of a high fiber whole grain rye diet, compared to a refined
wheat diet, on weight loss and body fat reduction. After a 2-week
run-in period, where all participants consumed wheat products,
participants were randomized (1:1) to consume either rye products
or wheat products for 12 weeks (Fig. 1). Rye and wheat products
were provided to the participants free of charge. During all 14
weeks all participants were instructed to adhere to a hypocaloric
diet aiming at a 500 kcal energy deficit. The first participant was
enrolled in the study in September 2016 and the last participant
finalized the intervention in December 2018. The study was con-
ducted at a research clinic in Uppsala Science Park and at the
clinical nutrition research lab at Uppsala University Hospital.
All participants gave written consent, after having received oral
and written information about the study, prior to initiating the
screening procedure. The study was approved by the Ethical2
Review Board in Uppsala (Dnr: 2016/254) and registered at www.
clinicaltrials.gov (Identifier: NCT03097237). The study was con-
ducted in accordance with the Declaration of Helsinki.
2.2. Study population
Participants were recruited through advertisements in news-
papers and on the internet, as well as through postings and dis-
tribution of flyers in public places such as shopping malls and
public libraries.
Men and women aged 30e70 years, with a BMI of 27e35 kg/m2,
were eligible to participate in the study. Furthermore, participants
were required to have hemoglobin120 g/L, serum thyroid stim-
ulating hormone4.00mIU/L, plasma low density lipoprotein (LDL)
cholesterol<5.3 mmol/L and plasma triglycerides1.8 mmoL/l at
the time of screening. Exclusion criteria included blood pressure
160/105 mmHg, use of nicotine products, strenuous physical ac-
tivity more than 10 h/week, history of gastrointestinal disease or
major gastrointestinal surgery (e.g. inflammatory bowel disease,
malabsorption, bowel resection, gastric bypass surgery), type-1
diabetes, pharmaceutically treated type-2 diabetes, thyroid disor-
der, use of medication or supplements with the aim of body weight
management within the past 6 months, adherence to a weight loss
diet within the past 6 months, pregnancy or lactation, heart attack
or stroke within past 12 months, and inability to consume any of
the foods included in the study (e.g. due to allergy).
BMI and blood pressure were measured after an overnight fast
at the first screening visit. Blood samples collected at the first
screening visit were sent to the Clinical Chemistry Laboratory at
Uppsala University Hospital within 4 h after collection and
analyzed within the same day. Participants filled in questionnaires
and underwent an interview with the study coordinator to deter-
mine eligibility according the inclusion and exclusion criteria.
After the first screening visit, participants were invited to
another screening visit 5 days later. Before the second screening
visit participants were required to complete a 3-day weighed food
record (3DWFR). The purpose of doing a 3DWFR at this stage was to
a) record the participant's habitual dietary intake, b) briefly screen
for any dietary habits that could be incompatible with the protocol
(e.g. vegan diets, low-calorie diets) and c) test the participant's
willingness to adhere to instructions.
At the second screening visit, results from analysis of blood
samples were assessed and exclusion criteria were re-checked to
make sure that the participant was eligible for participation. The
participant was provided with intervention foods and a fecal
collection kit, all future visits were scheduled, and the participant
was instructed to start the run-in period. During the run-in period
participants were required to lose at least 0.5 kg in order to be
enrolled and randomized into the 12-week parallel intervention
phase. For women menstruating during the run-in period, the
requirement for enrollment was no weight gain during the run-in
period. Participants were not informed about the weight loss
requirement during the run-in period.
2.3. Intervention products
The intervention products consisted of breakfast cereals, crisp
bread and soft bread, in both the rye group and in the wheat group
(Table 1). Breakfast cereals consisted of extruded rye and wheat
puffs, as well as rolled rye flakes and semolina wheat, packed in
30 g portions. Participants were instructed to consume two
packages per day but could choose freely if they wanted puffs or
flakes/semolina. Participants in the rye group had four different
rye crisp breads to choose from and were instructed to consume
4e6 slices per day (53e60 g/day), depending on the variety they
Fig. 1. Study design. Abbreviations: DXA, dual energy x-ray absorptiometry; 3DWFR, 3-day weighed food record.
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The wheat group had only one type of crisp bread and were
instructed to consume 5 slices per day (66 g/day). Crisp bread was
packed in portion packs to help participants consume correct
amounts andmake it easier to bring products when eating outside
the house. Soft bread was provided frozen in the form of wheat
buns or slices rye bread. The participants in the wheat group were
instructed to eat one wheat bun (70 g) per day, while the partic-
ipants in the rye group were instructed to consume 2e2.5 slices of
rye bread per day to reach a total of 16 slices per week (on average
119 g per day). All products were packed in neutral white or
transparent packaging material, but due to the visual differences
between rye and wheat, participants could not be blinded to their
allocation. The daily amount of interventions products amounted
to approx. 650 kcal in both groups, which corresponded to
approximately 30e50% of the participants daily energy intake.
The fiber content and composition differed substantially between
the groups, with the rye products providing approx. 30 g fiber/day
and the wheat products providing 8 g fiber/day (Table 1,
supplemental material 1).
Participants were instructed not to consume any other cereals
than the ones they received from the study, except for very small
amounts of “hidden” cereal (e.g. thickening in sauces). Every day
during the study, the participants filled in a pre-coded compliance
journal where they ticked off the products they consumed.
Furthermore, participants were instructed to note deviations from
the intervention diet, changes in habitual medication, or any cases
of illness in the journal as well.
2.4. Weight loss intervention
The aim for participants was to reach an energy deficit of
500 kcal/day, while maintaining a macronutrient distribution as
recommended in Nordic Nutrition Recommendations (NNR) 2012
(45e60 E% carbohydrate, 10e20 E% protein, 25e40 E% fat) [9]. All
participants had a personal meeting with a dietician around the
time they were scheduled to start the run-in period. The dieticians
reviewed the 3DWFR and interviewed the participant to get an
understanding of their habitual diet and calculated their energy
requirement following the equations, according to Henry et al. [22],
as presented in NNR 2012, assuming a physical activity level (PAL)3
of 1.4 [9]. Based on the habitual dietary pattern the dietician pro-
vided suggestions for dietary change based on the Step-wise
Weight-determined Accumulative Change Plan (SWAP) model,
developed by Bertz et al. [23], in order to reach the desired energy
deficit. The original SWAP model did not address fast-food intake,
but as most fast-food contain cereals which participants were
instructed to avoid, it was considered important for dieticians to
address this and a step concerning fast-food was added to the
model.
The following modified SWAP model was used in the Rye-
Weight-study:
1. Minimize the intake of sweets, cakes and soft drinks (limit to a
small amount (<100 g) once per week).
2. Minimize the intake of fast-food
3. Choose “keyhole” labelled products to minimize the intake of
sugar and fat
4. Increase the intake of vegetables (half the plate for lunch and
dinner).
5. Decrease portion sizes (while still maintaining a meal compo-
sition following the NNR recommendation).
Dieticians would implement the steps of the SWAP model into
the participants habitual diet in prioritized order. Hence, if a
participant had a high intake of foods mentioned in step one, this
would be the main focus, whereas if the intake of foods mentioned
in step one was not identified as being too high, then the focus was
moved to step two and so forth.
Dieticians contacted each participant by email or telephone af-
ter their visit to the clinic in week 2 for a follow-up consultation.
Follow-up consultations were done through email or phone
depending on the individual participants preference. Lastly, the
participants were informed that they could request additional
follow-up consultations with the dieticians at any time during the
study, if they had any problems or questions relating to the diet.
2.5. Randomization and blinding
After the 2-week run-in period the participants attended an
examination visit (week 0). First participants were weighed to
evaluate whether they had lost sufficient weight during the run-in
Table 1
Composition of intervention products, per 100 g edible product. Participants were instructed to consume 60 g breakfast cereals (puffs or flakes/semolina), 4e6 slice of crisp bread (53e66 g) and one serving of soft bread (Wheat:
















Total Extr. Unextr. Total Extr. Unextr.
Per 100 g edible product
Rye products
Extruded rye puffs 100 345.6 64.0 9.0 2.2 16.78 6.86 9.92 7.16 2.29 4.87 3.85 1.28 3.59 24.9 1.15
Rolled rye flakes 100 345.8 63.7 8.6 2.2 18.33 7.41 10.92 8.34 3.29 5.05 3.02 1.34 4.69 35.8 0.98
Rye crisp bread ‘Rågi’ 100 339.8 65.9 8.8 1.4 14.14 5.60 8.54 6.59 2.47 4.10 2.30 0.65 3.74 39.5 0.93
Rye crisp bread ‘Husman’ 100 335.6 63.1 9.0 1.5 16.95 6.65 10.30 8.16 2.98 5.18 2.45 1.24 4.18 39.7 1.00
Rye crisp bread ‘Sport’ 100 337.5 63.6 8.4 1.6 17.50 6.11 11.39 8.07 2.44 5.64 2.61 1.09 4.80 43.3 0.97
Rye crisp bread ‘Delikatess’ 100 336.1 61.0 10.0 1.5 19.27 7.39 11.88 8.43 2.54 5.89 3.79 1.19 4.96 38.3 0.97
Soft rye bread 100 225.6 34.4 7.5 4.1 10.62 3.75 6.87 4.54 1.50 3.04 1.52 1.04 2.92 32.9 0.86
Wheat products
Extruded wheat puffs 100 367.7 73.4 11.5 1.9 5.42 2.51 2.91 2.36 1.24 1.12 1.05 0.78 0.75 0.8 ndc
Wheat semolina 100 353.5 75.0 10.0 0.8 2.95 1.33 1.63 1.17 0.56 0.61 0.62 0.17 0.54 ndb ndb’’
Wheat crispbread 100 392.4 65.6 12.4 7.7 5.56 1.52 4.04 2.56 0.86 1.69 0.39 0.50 1.50 4.1 0.05
Soft wheat bread 100 252.2 43.3 13.7 1.9 3.53 1.03 2.50 1.24 0.76 0.49 0.15 0.71 1.05 1.6 ndc
Average daily amount of intervention products prescribed per protocol
Rye Mean 235 664 114.6 19.2 7.0 32.7 12.3 20.4 14.4 4.9 9.5 5.4 2.6 8.4 80.01 0.93
(minimum) (232) (656) (112.5) (18.8) (6.9) (30.2) (11.5) (18.7) (13.2) (4.5) (8.7) (4.8) (2.3) (7.6) (75.00) (0.91)
(maximum) (239) (679) (117.5) (19.8) (7.2) (34.2) (12.9) (21.6) (15.2) (5.4) (10.0) (6.2) (2.7) (9.2) (86.62) (0.95)
Wheat Mean 196 652 118.1 24.2 7.2 8.7 2.9 5.8 3.6 1.6 2.0 0.9 1.1 2.1 4.09 0.03
(minimum) (196) (648) (117.6) (23.8) (6.9) (7.9) (2.5) (5.4) (3.3) (1.4) (1.8) (0.7) (0.9) (2.0) (3.86) (0.03)
(maximum) (196) (656) (118.6) (24.7) (7.6) (9.4) (3.2) (6.2) (4.0) (1.8) (2.1) (1.0) (1.3) (2.2) (4.33) (0.04)
a Including arabinoxylans, fructans, klason lignin and glucose.
b no alkylresorcinol detected in the product.
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to be eligible, the examination continued as planned (see below)
and the participant was randomized. If the participant had not lost
sufficient weight, the examinationwas stopped, and the participant
was not randomized and was withdrawn from the study. The
randomization list was generated using the online tool www.
randomization.com, by random mixed block randomization with
block sizes 6, 8 and 10. Randomization was done by the study
coordinator.
Participants were not blinded due to the visual differences be-
tween rye and wheat products. Nurses and technicians conducting
the examinations of the participants were however blinded to
participants allocation. Dieticians met with participants before
randomization and were therefore not aware of the allocation at
the first consultation, however it is likely that some participants
revealed their allocation during the follow-up consultations.2.6. Study visits
At week 0, week 6 and week 12 participants attended an ex-
amination visit, which was conducted in the morning between the
hours of 7:00e11:30. Participants arrived at the clinic in fasted state
and brought with them a fecal sample. Participants were instructed
to avoid food and beverages from 20:00 the night before, except for
up to 500 ml plain tap water. Furthermore, participants were
instructed to avoid alcohol and intense physical activity for 24 h
prior to their visit to the clinic. Upon arrival to the clinic body-
weight, hip and waist circumference, and sagittal diameter was
measured. Body weight was measured to the nearest 0.1 kg with
participants wearing light clothing (underwear and t-shirt) on a
Tanita BC-545N scale (Tanita Corporation, Tokyo, Japan). Waist and
hip circumference were measured to the nearest 0.5 cm with a
measuring tape (Measuring tape 201, SECA Medical Measuring
Systems and Scales, Hamburg, Germany). Waist was measured at
the point of the navel and hip was measured at the widest point of
the hip. Participants were instructed to let arms hang down their
sides and take a deep breath. Measurement was done twice upon
exhalation, and an average was calculated. Sagittal diameter was
measured to the nearest 0.5 cm using a sagittal diametermeasuring
pin (BK-m€atare, AJ Medical, Liding€o, Sweden) with participant lying
on their back with legs bend. Participants were instructed to take a
deep breath and measurement was done twice at the point of the
navel upon exhalation. Average of the two measurements was
calculated. Height was measured only at the first screening visit
using a wall mounted roll-up measuring tape (Measuring tape 206,
SECA Medical Measuring Systems and Scales, Hamburg, Germany),
with participants wearing no shoes.
Thereafter participants were instructed to rest for 10 min in a
supine position before blood pressure was measured. Blood pres-
sure was measured twice using an automatic blood pressure
monitor (OMRON M6 AC, OMRON HEALTHCARE Co. Ltd., Kyoto,
Japan), and if measurements differed more than 5 mmHg a third
measurement was done. The average of all two/three measure-
ments was calculated. Immediately hereafter blood samples were
collected with participant remaining in the supine position. Finally,
participants filled in questionnaires (see below) and were provided
with intervention products and materials needed prior to next visit
(e.g. compliance journal and appetite assessment forms).
Participants underwent a total body dual energy x-ray absorp-
tiometry (DXA) scan (Lunar Prodigy, GE Medical Systems, Chicago,
Illinois, USA) for estimation of body composition. The DXA scanwas
conducted either on the same day as the examination, or on
another day in the sameweek. For majority of the participants (88%5
of conducted scans), DXA scans were conducted immediately after
the examinations without breaking the fast. Participants who had
DXA scans conducted on another day were instructed to fast (avoid
all food or beverages) for minimum 3 h prior to the DXA scan. The
precision errors on triple DXA scans in 15 participants, including
repositioning, were 0.8e1.5% depending on type of measurement.
The long-term coefficient of variation was less than 1% for a spine
phantom. The validity of fat mass derived by Lunar Prodigy has
been evaluated against the 4-compartment model, the tool that is
currently considered the gold standard method of body composi-
tion appraisal, resulting in 1.7e2.0% higher fat mass estimates with
the narrow fan-beam DXA equipment [24].
Besides examination visits in week 0, 6 and 12, the participants
visited the clinic in weeks 2, 4, 8 and 10 to collect intervention
products and other materials needed for future visits (e.g. fecal
collection kits and 3DWFR).
2.7. Appetite assessment
Participants conducted a full day appetite assessment at home
between visits in week 0e2, week 4e6 and week 10e12. During
this day, the participants followed a standardized meal plan,
including intervention products according to allocation. During the
day the participants answered questions about their appetite every
30 min from 8:00e12:00 and every 60 min from 13:00e22:00.
At each time point participants answered three questions in
random order: “How hungry are you?”, “How full are you?”, “How
strong is your desire to eat?”. Questions were answered on a 100-
point visual analogue scale with following words anchored at
each end: “Not hungry at all/I have never felt more hungry”, “Not
full at all/Extremely full” and “Not strong at all/Extremely strong”.
Questions were sent to participants by email using the online sur-
vey tool Qualtrics (Qualtricsxm, Seattle, Washington, USA), and the
participants could answer questions on their mobile device, com-
puter or similar. All participants were provided with questions on
papers as well, in case they could not use email, or experienced
technical problems during the day. When answering questions on
paper, participants were asked to note the time and date on the
questionnaires, place the questionnaires in sealed envelopes (one
envelope per timepoint) and bring them to the clinic at next visit.
During the day of the appetite assessment the participants had a
checklist that contained all scheduled questions and meals. Par-
ticipants were asked to note any deviations in the checklist and
hand it in at their next visit to the clinic. During the day of the
appetite assessment the participants followed a meal plan that was
adjusted to match the energy need for each participant with an
energy deficit of 500 kcal. The meal plans included intervention
products according to group allocation and all foods needed for the
days was provided to the participants. Immediately after answering
the first questions at 8:00 the participants consumed a breakfast
meal consisting of puffs and milk. For lunch, immediately after
12:00 questions, participants consumed a ready-to-eat goulash
soup with crisp bread and butter/cheese. At 15:00 participants had
a snack meal consisting of crisp bread, yoghurt and jam/butter.
Immediately after answering questions at 18:00 participant
consumed a dinner of tomato soup, soft bread and cheese/butter. At
20:00 participant had a snack meal of crisp bread, butter/jam and
sesame crackers. Participants were allowed 300 ml of water, tea or
coffee with each meal. At first appetite assessment day participants
chose and recorded their choice of beverage andwere then asked to
have the same beverages on later appetite assessment days. If
participants felt very thirsty during the day, they could consume
maximum 100 ml extra water at least 30 min before next question
was scheduled to be answered.
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Participants were instructed to conduct a 3DWFR between the
screening visits, between week 4e6 and between week 10e12.
Participants were instructed to record everything they ate or drank
during two weekdays and one weekend day. They were instructed
to use scales as much as possible, and to use household measures
(e.g. deciliter or slices) to estimate amounts when it was not
possible to weigh the food. Daily energy and macronutrient intake
were calculated using the software DietistNetPro (www.kostdata.
se, Kost och N€aringsdata AB, Bromma, Sweden) which contains a
brand specific databased developed for use in Sweden and linked to
the food composition database provided by the National Food
Agency in Sweden. In case of missing information about the
amount of specific food items in the 3DWFR standard portions in
the software was used. Additionally, foods were grouped into food
groups and the daily intake of each food group was calculated. The
grouping of foods was based on the method used in a national di-
etary intake surveys conducted by the Swedish Food Agency,
Riksmaten [25].
2.9. Compliance evaluation
Compliance was evaluated using pre-coded compliance jour-
nals, as previously described, and the daily intake of intervention
products was calculated. As pre-defined in the study protocol, a
participant was considered to be compliant if he/she consumed
minimum 80% of the daily amount of products (weight/weight) on
average over the 12-week intervention period. Plasma alkylre-
sorcinols (AR), biomarkers of whole grain rye and wheat intake
[26], were analyzed as a supporting measure of compliance.
2.10. Questionnaires
At screening, week 0, week 6 and week 12 participants filled in
questionnaires on physical activity and gastrointestinal symptoms.
Physical activity was assessed using the questionnaire developed
by Baecke et al., and an activity score for work, sport and leisure
time activities was calculated as per the method described by the
developer of the questionnaire [27]. Activity level of sports reported
by the participants that were not mentioned in the original publi-
cation of the questionnaire were evaluated using the compendium
of physical activity by Ainsworth et al. [28]. Gastrointestinal
symptoms was assessed using the GSRS-IBS questionnaire and
participants answers were transformed into subscale symptom
scores using the method described by Wiklund et al. [29].
Eating behavior was assessed at the first screening visit using
the 21-item Three Factor Eating Questionnaire (TFEQ), which is
evaluating participant’s behavior with regards to three different
domains; cognitive restrained eating, uncontrolled eating and
emotional eating [30]. Furthermore, the participants filled in a
demographic questionnaire developed for study to record back-
ground information, such as educational level, occupation and
housing.
2.11. Biological samples
At week 0, week 6 and week 12 blood samples were collected in
6 ml K2E EDTA tubes, 4 ml sodium heparin tubes and 5 ml serum
glass tubes (BD Vacutainer, Beckton Dickinson, Franklin Lakes, New
Jersey, USA). As a standard procedure in our laboratory we also
collected samples in 4.5 ml sodium citrate tubes and 2.5 ml PAX-
gene tubes, which were processed and stored for potential later
use. Serum tubes were kept at room temperature before, during6
and after sampling, whereas EDTA, citrate and heparin tubes were
kept on ice from before sampling until centrifugation.
EDTA, heparin and citrate tubes were centrifugated immediately
after sampling at 4 C and 2500 g, for 10 min, whereafter plasma
was transferred into screw cap micro tubes (Sarstedt AG & Co.,
Nümbrecht, Germany), before being placed in 20 C freezer.
Erythrocytes and buffy coat from the EDTA tubes were likewise
transferred to micro tubes and stored for potential later use as a
standard procedure in our laboratory. Serum tubes were kept at
room temperature for 60min, prior to centrifugation and thereafter
the serum was transferred into screw cap microtubes and stored
at 20 C. PAXgene tubes were kept at room temperature for 2 h
and transferred to 20 C for a minimum of 24 h before being
transferred to 80 C. Spot fecal samples were collected as a
standard procedure in our laboratory and stored for later use. All
samples were kept in20 C freezer for max duration of 7 days, and
then transferred to 80 C freezer for long term storage in a
biobank.
Blood samples were analyzed at the Department of Clinical
Chemistry at Uppsala University Hospital for selected metabolic
biomarkers. Insulinwasmeasured in serum using a noncompetitive
immunoassay. Remaining markers were analyzed in sodium hep-
arin plasma using immunoturbidimetric assay (C-reactive protein
(CRP)), hexokinase method (glucose) and enzymatic colorimetric
assays (lipids). All measurement was done on Cobas® Pro (Roche
Diagnostics, Basel, Switzerland) according to standardized pro-
cedures at the laboratory (coefficient of variance<10%). Some
samples had CRP concentration below the detection limit (0.2 mg/
L) and were therefore assigned a value of half the detection limit
(2.6% of the samples). Homeostatic model assessment for insulin
resistance (HOMA-IR) was calculated as (insulin (mIU/L) x glucose
(mmol/L))/22.5 [31].
AR were measured in EDTA plasma at Chalmers Mass Spec-
trometry Infrastructure using liquid chromatography tandem mass
spectrometry according to a method developed at the platform
[32]. Total plasma AR concentration was calculated as a sum of
homologues C17:0-C25:0 and was used as a biomarker of whole
grain intake from rye and wheat sources, while the AR C17:0/C21:0
homologue ratio was calculated as marker of the proportion whole
grain from wheat and rye sources. Since the C17:0 homologue is
primarily present in rye, a higher ratio C17:0/C21:0 indicate that a
larger proportion of the consumedwhole grain cereals are from rye,
while a low ratio indicate that the intake is primarily from wheat
[33]. The inter- and intra assay coefficient of variance was <15% for
all batches analyzed.
2.12. Statistical analyses
The number of subjected needed for the study was estimated
based on two primary endpoints (body weight and body fat per-
centage), with power of 80% and alpha of 2.5%. The number of
subjects needed to detect an effect of 1 kg difference in bodyweight
(standard deviation: 2.4 kg [34]) and 1% difference in body fat
percentage (standard deviation 1.5% [35]) after 12 weeks, was
estimated to be 106 participants in each treatment group. Based on
experience from previous studies, we aimed to randomize 260
participants (130/treatment group) to allow for 18% drop-out rate.
Due to having two primary endpoints, Bonferroni adjustment was
applied to the primary outcomes, and therefore the significance
level was set to p < 0.025 for the primary outcomes. For remaining
outcomes significance level was p < 0.050.
Differences between treatments were evaluated using the PROC
MIXED procedure in SAS statistical software version 9.4 (SAS
institute, Cary, USA). Week and week*diet were included as fixed
factors, and a REPEATED statement specifying an unstructured
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included. Models were comparing the groups at week 6/week 12
and were adjusted for baseline (week 0). Furthermore, models
evaluating metabolic markers were also adjusted for weight
change. Normality was evaluated using residual plots and histo-
grams. Data was log transformed prior to analysis if deviating from
a normal distribution, and estimates were back transformed to the
original scale after analysis.
Primary outcomes of the study were complete cases analysis of
the difference in body weight and body fat percentage, between
diets after 12 weeks of intervention as defined in the study pro-
tocol. Secondary outcomes were differences of additional anthro-
pometric and clinical outcomes measures (e.g. body fat mass, lean
body mass, waist-hip ratio, blood pressure) between diets after 6
and 12 weeks of intervention, body weight and body fat percentage
after 6 weeks of intervention and differences in appetite responses.
In the complete cases analysis, a completed case was defined as a
participant who had completed the 12-week intervention and
participated in the final examination at week 12.
As a secondary analysis, two intention to treat (ITT) analyses
were conducted on the primary and secondary outcomes. In these
analyses, all randomized participants were included irrespective of
whether they completed the 12-week intervention or dropped out
during the intervention. ITT analysis was conducted using last
observation carried forward (LOCF), where missing values were
imputed by the last observed value, as well as by linear mixed
modelling using the PROC MIXED procedure without imputation of
missing data, as defined in the statistical analysis plan.
Area under the curve (AUC) for appetite response was calculated
using the trapezoid method. AUC was calculated for the entire day
(8:00e22:00), morning (8:00e12:00), afternoon (12:00e18:00)
and evening (18:00e22:00). AUC appetite data was analyzed using
the same method as anthropometric outcomes (above), though
without baseline adjustment. Repeated appetite response was
analyzed separately for each week, in the same way as AUC appe-
tite, but using time of day rather than week as the repeated factor.
Correlations were calculated using the PROC CORR procedure,
specifying Pearson's correlation for normally distributed data and
Spearman's rank correlationwhendatawas not normally distributed.3. Results
In total 590 participants were screened for the study of which
317 fulfilled the criteria and initiated the run-in period (Fig. 2).
During the run-in period, 36 subjects withdrew from the study,
mainly due to not being willing to follow intervention diet or dif-
ficulties fitting the logistics of the study into their daily life.
Furthermore, 39 participants were excluded from the study due to
not achieving sufficient weight loss during the run-in period (lost
<0.5 kg). In total, 242 participants completed the run-in period
with sufficient weight loss and were enrolled and randomized into
the 12-week parallel intervention. During the 12-week interven-
tion 14% of the participants dropped out. Main reason for drop-out
was related to the diet. Participants became tired of the products or
experienced stomach problems (mainly bloating and flatulence)
due to the change in diet. Furthermore, some participants dropped
out due to difficulties fitting study visits into working hours and/or
family life. Four participants dropped out due to various illnesses,
none of which are related to the study or the intervention. In total,
207 participants completed the 12-week intervention (Fig. 2).
At baseline, the groups did not differ in terms of anthropo-
metrics and demographic factors and sex distribution was similar7
(40% males). Furthermore, no baseline difference in terms of the
factors evaluated in the TFEQ was observed between the groups
(Table 2).
Physical activity level remained stable throughout the study and
the were no differences between the groups at any time point
(Supplemental Table 1).
For gastrointestinal symptoms, the groups did not differ in
terms of abdominal pain or diarrhea (Supplemental Fig. 1). How-
ever, during the 12-week intervention, participants in the rye group
felt more bloated and less constipated compared the participants in
the wheat group. Nevertheless, it should be noted that both groups
had relatively low symptom scores throughout the study (1e2.5 of
5), indicating that participants had relatively few symptoms both
before and during the study.3.1. Compliance
Compliance, assessed by compliance journals, showed a high
degree of compliance to the intervention with participants
reporting consumption of about 94e95% of the products on average
over the 12-week intervention, as well as during the run-in period
(Table 3). The participants in the rye group consumed an average of
30.7 g of dietary fiber per day from the intervention products,
whereas the wheat group consumed 8.5 g of dietary fiber per day
(Table 3).
Similarly, concentration of AR in plasma also indicated an overall
good compliance (Table 4). The groups had similar and low con-
centration of total AR and C17:0/C21:0 ratio at baseline, which is to
be expected as they had consumed refined wheat products during
the 2-week run in period. Both total AR concentration and C17:0/
C21:0 wasmarkedly higher in the rye group at week 6 andweek 12,
compared to the wheat group, showing a higher intake of whole
grain, primarily sourced from rye. It should be noted that the total
AR concentration seemed to decrease slightly in the rye group
between week 6 and week 12, which could indicate that the
compliance was somewhat better during the first part of the
intervention. The AR concentration in the wheat group remained
stable throughout the entire intervention period indicating good
compliance to a refined wheat diet.3.2. Dietary intake
Energy intake did not differ between the groups before or
during the intervention, and the daily energy intake was reduced
by 100e200 kcal during the intervention in both groups (Table 5).
The dietary fiber intake in the wheat group remained relatively
stable throughout the intervention, whereas the dietary fiber
intake increased in the rye group and was significantly higher
than the intake in the wheat group at week 6 and 12. The differ-
ence between groups in dietary fiber intake estimated from the
3DWFR corresponds approximately to the difference in dietary
fiber intake found in the compliance journals (approx. 20 g/day)
(Tables 3 and 5). The protein intake seemed to be slightly higher in
the wheat group, compared to the rye group, in week 12, but
otherwise the macronutrient intake did not differ between the
groups (Table 5).
Table 5 show intake of different food groups calculated from the
3DWFR. The total cereal food intake was higher in the rye group,
compared to the wheat group throughout the intervention, but this
can be explained by the fact that weight of the prescribed rye
products was higher than the prescribed amount of wheat products
(235 vs. 196 g/day, Table 1) in order to reach the same amount of
Fig. 2. Flow diagram of participants.
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in the wheat group compared with the rye group (60e70 g/day
difference). This may be due to fact that the participants in the
wheat group preferred puffs, commonly eaten with milk or
yoghurt, over semolina porridge, whereas the participants in the
rye group had a more even distribution between puffs and rye
flakes. In the rye group, puffs accounted for 64% of the breakfast
cereal intake, while puffs accounted for 74% of the breakfast cereal
intake in thewheat group. The higher dairy intake could potentially
explain the higher protein intake in the wheat group.
Both the rye and wheat group reduced their intake of sweets
and snacks by approx. 50% (Table 5). This is in linewith the first step
of the SWAP model used by dieticians, and it is therefore plausible
that reduction of food from this category has been the main focus
across all participants.8
3.3. Body weight and body fat e primary outcomes
Evaluation of the primary outcomes, completed cases analysis of
body weight and body fat percentage at week 12, showed that the
body weight in the rye group was significantly lower than the
bodyweight in the wheat group (p ¼ 0.0036) (Table 6). On average,
the rye group lost 2.9 kg (hereof 2.7 kg fat) during the 12-week
intervention, while the wheat group lost 1.8 kg (hereof 1.8 kg fat)
(Tables 6 and 7). The rye group had a lower body fat percentage at
week 12, compared to the wheat group, but this difference was
borderline significant after adjustment for multiple endpoints
(p ¼ 0.0307, significance level: p < 0.025). Both approaches for ITT
analyses confirmed the difference between the groups in body
weight and body fat mass, and furthermore, the difference in body
fat percentage was significant in both ITT analyses approaches even
Table 2
Baseline characteristics of enrolled participants.
Rye (n ¼ 121) Wheat (n ¼ 121)
Anthropometrics and demographics
Sex (f/m) (%females) 71/50 (59%) 76/45 (63%)
Age (years) 56.5 ± 9.7 56.9 ± 9.5
Body weight (kg) 88.2 ± 12.5 88.8 ± 12.5
BMI (kg/m2) 29.7 ± 2.4 30.3 ± 2.4
Body fat (%) 39.1 ± 6.6 40.8 ± 7.2
Education level (highest completed)
Primary school 7 (6%) 11 (9%)
2 year high-school program/vocational training 20 (17%) 18 (15%)
3e4 year high-school program 15 (12%) 23 (19%)
University 78 (65%) 67 (55%)
Other/unknown 1 (1%) 2 (2%)
Current occupation
Employed 83 (69%) 69 (57%)
Self-employed 12 (10%) 12 (10%)
Temporarily unemployed 0 (0%) 1 (1%)
Parental leave 0 (0%) 1 (1%)
Studying 1 (1%) 1 (1%)
Retired 23 (19%) 29 (24%)
Sick leave/early retirement 0 (0%) 3 (2%)
Other/unknown 2 (2%) 5 (4%)
Housing
Apartment, rented 14 (12%) 17 (14%)
Apartment, owned 35 (29%) 31 (31%)
House, rented 1 (1%) 3 (2%)
House, owned 68 (56%) 66 (55%)
Other/unknown 3 (2%) 4 (4%)
Share household with other adults (18 y) 100 (83%) 96 (79%)
Share household with children (<18 y) 38 (31%) 32 (26%)
Living alone 17 (14%) 23 (19%)
Country of birth
Sweden 102 (84%) 110 (91%)
Other country in the European Union 7 (6%) 4 (3%)
Outside the European Union 11 (9%) 6 (5%)
Unknown 1 (1%) 1 (1%)
Three factor eating questionnaire (TFEQ)
Restrained eating 13.5 ± 2.9 13.8 ± 2.9
Emotional eating 13.6 ± 4.2 14.2 ± 4.5
Uncontrolled eating 20.4 ± 4.6 20.3 ± 5.0
Data is n (%) or mean ± SD.
Table 3
Daily average intake of intervention products over 2 weeks (run-in period) and 12 weeks (rye group and wheat group) according to compliance journals.
Weight (g) Energy (kcal) Carbo-hydrate (g) Protein (g) Fat (g) Dietary fiber (g) % of products eaten
(weight/weight)a
Run-in period (n ¼ 207) 186.4 ± 14.4 (191) 619.5 ± 50.4 (637.6) 111.9 ± 9.3 (115) 23.2 ± 1.7 (23.7) 6.9 ± 0.6 (7.2) 8.4 ± 0.7 (8.5) 95.1 ± 7.4 (97.4)
Wheat group (n ¼ 99) 185.4 ± 11.8 (188.9) 618.3 ± 39.1 (627.8) 111.6 ± 7.1 (113.4) 23.1 ± 1.5 (23.5) 7 ± 0.6 (7.1) 8.5 ± 0.6 (8.6) 94.6 ± 6.0 (96.4)
Rye group (n ¼ 108) 221.4 ± 20.6 (228.4) 626.8 ± 54.3 (644) 108.4 ± 9.2 (111.2) 18.1 ± 1.6 (18.7) 6.6 ± 0.7 (6.8) 30.7 ± 2.6 (31.5) 94.2 ± 8.8 (97.2)
Data is mean ± SD(median).
a Consumed amount of the prescribed products, 100% indicate perfect compliance.
Table 4
Total plasma alkylresorcinol concentration and the ARC17:0/C21:0 homologue ratio.
N: rye ¼ 108, wheat ¼ 99. Data is geometric mean (95% confidence interval).
Week 0 Week 6 Week 12
Total alkylresorcinol (nmol/L)
Wheat 79 (70; 88) 71 (64; 79) 73 (65; 83)
Rye 72 (64; 80) 531 (478; 589) 457 (405; 515)
C17:0/C21:0 homologue ratio
Wheat 0.06 (0.05; 0.07) 0.06 (0.05; 0.06) 0.07 (0.06; 0.08)
Rye 0.06 (0.05; 0.06) 0.40 (0.36; 0.45) 0.41 (0.37; 0.46)
Data is geometric mean (95% confidence interval).
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Body weight differed between the groups already after 6 weeks of
intervention (0.6 kg, p ¼ 0.0071), though to a lesser extent than
after 12 weeks (1.1 kg, p ¼ 0.0036).9
3.4. Secondary anthropometric outcomes and clinical markers
BMI, fat mass, waist and hip circumference were lower in the rye
group than in thewheat group after 12 weeks of intervention, which
is to be expected due the higher weight loss (Table 7). Lean mass did
not differ between the groups and did not decrease in either of the
groups, showing that the weight reduction was primarily due to a
reduction in fat mass. Waist-to-hip ratio was not affected by the
intervention, which is likely because waist and hip circumference
was reduced to a similar extent during the intervention, meaning
that the ratio remained unchanged. Blood pressure did not differ
between the groups and remained stable throughout the interven-
tion (Table 8). However, it should be noted that the average blood
pressure in both groups were within normal range (approx. 125/
80 mmHg) at week 0, leaving little room for improvement.
Table 5
Average daily dietary intake according to 3-day weighed food records.






Energy (kcal/day) Rye 2173 ± 5312 (2122) 1953 ± 435 (1884) 2001 ± 496 (1976) 0.402 0.969 0.687
Wheat 2118 ± 550 (2020) 1958 ± 469 (1871) 2026 ± 468 (1909)
Protein (g/day) Rye 87 ± 23 (82) 89 ± 22 (84) 87 ± 23 (87) 0.984 0.366 0.012
Wheat 87 ± 24 (84) 92 ± 21 (91) 95 ± 25 (91)
Fat (g/day) Rye 93 ± 28 (91) 75 ± 26 (70) 80 ± 28 (78) 0.959 0.711 0.807
Wheat 94 ± 30 (88) 77 ± 31 (73) 81 ± 29 (76)
Carbohydrate (g/day) Rye 219 ± 65 (211) 201 ± 38 (200) 202 ± 49 (197) 0.593 0.449 0.145
Wheat 208 ± 64 (207) 205 ± 50 (200) 207 ± 44 (201)
Dietary fiber (g/day) Rye 22 ± 8 (21) 38 ± 9 (38) 37 ± 9 (38) 0.055 <0.001 <0.001
Wheat 21 ± 6 (20) 20 ± 7 (19) 19 ± 5 (18)
E% protein Rye 17 ± 4 (16) 18 ± 3 (18) 18 ± 3 (17) 0.520 0.139 0.001
Wheat 17 ± 3 (16) 19 ± 3 (18) 19 ± 3 (18)
E% fat Rye 38 ± 6 (39) 34 ± 6 (34) 35 ± 6 (36) 0.150 0.443 0.934
Wheat 40 ± 7 (40) 35 ± 8 (35) 35 ± 7 (35)
E% carbohydrate Rye 40.1 ± 6.1 (41) 40.1 ± 6.1 (41) 40.1 ± 6.1 (41) 0.206 0.680 0.678
Wheat 39.4 ± 7.1 (40) 39.4 ± 7.1 (40) 39.4 ± 7.1 (40)
E% dietary fiber Rye 2.1 ± 0.6 (2) 4.0 ± 1.0 (4) 3.8 ± 1.0 (4) 0.204 <0.001 <0.001
Wheat 2.0 ± 0.5 (2) 2.1 ± 0.6 (2) 1.9 ± 0.6 (2)
E% alcohol Rye 3 ± 4 (2) 3 ± 3.0 (0) 2 ± 4 (0) 0.696 0.166 0.282
Wheat 3 ± 3 (1) 2.2 ± 3 (0) 3 ± 4 (1)
Fruit and vegetables (g/day) Rye 364 ± 175 (346) 382 ± 179 (365) 351 ± 164 (335) 0.065 0.229 0.060
Wheat 336 ± 174 (313) 364 ± 194 (342) 317 ± 151 (310)
Potatoes (g/day) Rye 71 ± 70 (53) 77 ± 69 (65) 80 ± 70 (70) 0.427 0.337 0.493
Wheat 63 ± 58 (52) 65 ± 58 (50) 87 ± 73 (68)
Cereals (g/day) Rye 234 ± 120 (223) 232 ± 88 (218) 227 ± 74 (222) 0.069 <0.001 <0.001
Wheat 209 ± 98 (193) 184 ± 46 (187) 181 ± 44 (191)
Meat (g/day) Rye 134 ± 77 (121) 127 ± 75 (112) 127 ± 76 (114) 0.677 0.212 0.561
Wheat 129 ± 64 (127) 110 ± 79 (100) 129 ± 91 (108)
Seafood and caviar (g/day) Rye 50 ± 56 (33) 46 ± 41 (40) 49 ± 51 (40) 0.273 0.091 0.223
Wheat 46 ± 41 (40) 38 ± 37 (37) 42 ± 41 (33)
Eggs (g/day) Rye 30 ± 30 (23) 26 ± 32 (17) 28 ± 30 (17) 0.250 0.059 0.140
Wheat 36 ± 40 (20) 36 ± 41 (22) 36 ± 39 (22)
Dairy (excluding cheese) (g/day) Rye 271 ± 149 (258) 348 ± 152 (333) 357 ± 174 (333) 0.335 0.006 0.025
Wheat 295 ± 196 (243) 416 ± 200 (407) 417 ± 211 (383)
Cheese (g/day) Rye 42 ± 28 (40) 39 ± 32 (32) 37 ± 24 (34) 0.606 0.809 0.737
Wheat 44 ± 35 (34) 40 ± 37 (33) 38 ± 33 (30)
Oil, butter and margarine (g/day) Rye 16 ± 12 (13) 15 ± 12 (12) 15 ± 12 (13) 0.048 0.322 0.308
Wheat 20 ± 17 (18) 17 ± 19 (12) 18 ± 16 (15)
Sweets, snacks, candy, cakes,
desserts, sweeteners (g/day)
Rye 109 ± 82 (96) 42 ± 47 (30) 51 ± 50 (38) 0.167 0.962 0.626
Wheat 93 ± 76 (80) 4 ± 57 (26) 49 ± 62 (33)
Data is mean ± SD(median).
a n ¼ rye/wheat.
Table 6
Primary outcomes (complete case analysis).
Week 0a Week 6a Week 12a Dbetween groups wk 6b Dbetween groups wk 12b p wk 6b p wk 12b
Body weight (kg) Wheat 89.14 ± 1.26 87.83 ± 1.24 87.35 ± 1.27 0.60 (0.17; 1.04) 1.08 (0.36; 1.80) 0.0071 0.0036
Rye 88.83 ± 1.21 86.93 ± 1.19 85.97 ± 1.21
Body fat (%) Wheat 40.69 ± 0.69 39.83 ± 0.73 39.37 ± 0.75 0.22 (0.1; 0.53) 0.54 (0.05; 1.03) 0.1831 0.0307
Rye 38.88 ± 0.66 37.75 ± 0.7 36.92 ± 0.72
Data is ‘mean ± SEM’, ‘mean (95%confidence interval)’. Due to two primary endpoints, significance level is p < 0.025, significant p-values are marked in bold font. n: rye ¼ 108,
wheat ¼ 99.
a LSMEANS, not adjusted for baseline.
b Derived from baseline adjusted model, rye group is reference for confidence intervals.
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ondary outcomes. LDL cholesterol differed between groups after 6
weeks of intervention (p ¼ 0.013), while this difference was
attenuated at week 12 (p ¼ 0.095). Interestingly, the difference was
caused by an increased LDL cholesterol concentration in the refined
wheat group, rather than a decrease in the rye group.
CRP was lower in the rye group, compared to the wheat group,
after both 6 (p ¼ 0.019) and 12 (p ¼ 0.001) weeks of intervention.
The difference was driven by a reduction in CRP concentration in
the rye group, and after 12 weeks of intervention the concentration10in the rye groupwas 39% lower than the concentration in thewheat
group. Removing observations higher than 10 mg/L (2.6% of the
samples), which could indicate acute inflammation rather than low
grade inflammation, reduced the difference between the groups
but the CRP concentration in the rye group was still lower than the
wheat group after both 6 (21%, p ¼ 0.033) and 12 (28%, p ¼ 0.008)
weeks of intervention.
Both CRP and LDL cholesterol are known to be positively
affected by weight reduction, but we found no correlations be-
tween weight loss and LDL (Week 6: r ¼ 0.05, p ¼ 0.45. Week 12:
Table 7
Secondary outcomes (complete case analysis).
Week 0a Week 6a Week 12a Dbetween groups wk 6b Dbetween groups wk 12b p wk 6b p wk 12b
BMI (kg/m2) Wheat 30.35 ± 0.25 29.89 ± 0.25 29.72 ± 0.26 0.19 (0.05; 0.33) 0.33 (0.09; 0.57) 0.0098 0.0067
Rye 29.83 ± 0.24 29.29 ± 0.24 28.88 ± 0.25
Waist (cm) Wheat 102.58 ± 0.95 100.76 ± 0.92 100.56 ± 1.99 1.11 (0.15; 2.36) 1.90 (0.49; 3.30) 0.0834 0.0083
Rye 103.16 ± 0.91 100.15 ± 0.88 99.19 ± 0.96
Hip (cm) Wheat 106.97 ± 0.67 105.91 ± 0.66 105.67 ± 0.72 0.94 (0.19; 2.07) 1.65 (0.40; 2.89) 0.1013 0.0098
Rye 106.21 ± 0.65 104.39 ± 0.63 103.39 ± 0.69
Waist-to-hip ratio Wheat 0.96 ± 0.01 0.95 ± 0.01 0.95 ± 0.01 0.00 (0.01; 0.01) 0.00 (0.00; 0.01) 0.586 0.727
Rye 0.97 ± 0.01 0.96 ± 0.01 0.96 ± 0.01
Sagittal diameter (cm) Wheat 22.05 ± 0.27 21.61 ± 0.26 21.45 ± 0.28 0.00 (0.37; 0.37) 0.25 (0.22; 0.73) 0.9932 0.2933
Rye 22.37 ± 0.26 21.86 ± 0.25 21.46 ± 0.27
Fat mass (kg) Wheat 35.81 ± 0.69 34.56 ± 0.7 34.01 ± 0.73 0.42 (0.04; 0.80) 0.90 (0.25; 1.55) 0.0319 0.0068
Rye 34.01 ± 0.66 32.35 ± 0.67 31.31 ± 0.7
Lean mass (kg) Wheat 49.47 ± 1.05 49.53 ± 1.07 49.65 ± 1.08 0.18 (0.12; 0.48) 0.20 (0.14; 0.55) 0.2468 0.2461
Rye 50.94 ± 1.01 50.84 ± 1.02 50.96 ± 1.04
Fat - gynoid (kg) Wheat 6.37 ± 0.14 6.14 ± 0.14 6.04 ± 0.14 0.06 (0.01; 0.13) 0.11 (0.00; 0.23) 0.1106 0.0554
Rye 5.92 ± 0.14 5.65 ± 0.14 5.51 ± 0.14
Fat - android (kg) Wheat 3.57 ± 0.09 3.40 ± 0.09 3.35 ± 0.09 0.03 (0.03; 0.08) 0.14 (0.06; 0.23) 0.3121 0.0010
Rye 3.44 ± 0.09 3.25 ± 0.08 3.09 ± 0.09
Data is ‘mean ± SEM’, ‘mean (95%confidence interval)’. Significance level is p > 0.05, significant p-values are marked in bold font. n: rye ¼ 108, wheat ¼ 99.
a LSMEANS, not adjusted for baseline.
b Derived from baseline adjusted model, rye group is reference for confidence intervals.
Table 8
Secondary outcomes (complete case analysis).
Week 0a Week 6a Week 12a Dbetween groups wk 6b Dbetween groups wk 12b p wk 6b p wk 12b
Mean ± SEM Mean difference (95% CI)
Systolic BP (mmHg) Wheat 123.82 ± 1.51 123.61 ± 1.53 123.08 ± 1.39 0.64 (2.88; 1.60) 1.11 (3.45; 1.23) 0.575 0.351
Rye 126.26 ± 1.45 126.26 ± 1.47 125.81 ± 1.33
Diastolic BP (mmHg) Wheat 78.73 ± 0.87 78.47 ± 0.91 77.86 ± 0.86 0.14 (1.38; 1.11) 0.33 (1.63; 0.97) 0.827 0.615
Rye 79.64 ± 0.84 79.39 ± 0.87 78.84 ± 0.82
Pulse (bpm) Wheat 62.67 ± 0.86 62.04 ± 0.84 61.95 ± 0.83 0.52 (1.00; 2.04) 0.62 (0.97; 2.22) 0.502 0.440
Rye 61.96 ± 0.82 60.9 ± 0.80 60.72 ± 0.79
Glucose (mmol/L) Wheat 5.61 ± 0.06 5.56 ± 0.06 5.54 ± 0.06 0.03 (0.07; 0.13) 0.04 (0.05; 0.14) 0.609 0.355
Rye 5.53 ± 0.05 5.46 ± 0.06 5.42 ± 0.06
Total cholesterol (mmol/L) Wheat 4.77 ± 0.09 4.88 ± 0.09 4.89 ± 0.09 0.09 (0.04; 0.22) 0.04 (0.08; 0.17) 0.177 0.502
Rye 4.69 ± 0.09 4.71 ± 0.09 4.77 ± 0.09
HDL cholesterol (mmol/L) Wheat 1.43 ± 0.03 1.45 ± 0.03 1.49 ± 0.03 0.01 (0.02; 0.05) 0.03 (0.00; 0.07) 0.424 0.070
Rye 1.37 ± 0.03 1.38 ± 0.03 1.40 ± 0.03
LDL cholesterol (mmol/L) Wheat 3.07 ± 0.08 3.18 ± 0.08 3.17 ± 0.08 0.14 (0.03; 0.25) 0.10 (0.02; 0.21) 0.013 0.095
Rye 3.07 ± 0.08 3.04 ± 0.08 3.07 ± 0.08
Geometric mean (95% CI)d Anti-log mean difference (95% CI)d
Triglycerides (mmol/L) Wheat 1.10 (1.03; 1.17) 1.11 (1.04; 1.19) 1.10 (1.03; 1.17) 0.98 (0.92; 1.04) 0.95 (0.89; 1.01) 0.545 0.091
Rye 1.08 (1.02; 1.16) 1.12 (1.05; 1.19) 1.14 (1.07; 1.22)
Insulin (mIU/L) Wheat 9.83 (8.98; 10.75) 9.54 (8.69; 10.49) 9.11 (8.27; 10.04) 1.09 (1.00; 1.19) 1.04 (0.94; 1.14) 0.059 0.442
Rye 9.05 (8.30; 9.86) 8.15 (7.45; 8.92) 8.18 (7.45; 8.97)
CRP (mg/L) Wheat 1.44 (1.19; 1.74) 1.48 (1.22; 1.8) 1.58 (1.29; 1.92) 1.27 (1.04; 1.55) 1.39 (1.15; 1.70) 0.019 0.001
Rye 1.45 (1.21; 1.73) 1.16 (0.96; 1.39) 1.12 (0.93; 1.36)
CRPc (mg/L) Wheat 1.40 (1.17; 1.67) 1.38 (1.15; 1.64) 1.44 (1.19; 1.73) 1.21 (1.02; 1.44) 1.28 (1.07; 1.53) 0.033 0.008
Rye 1.37 (1.16; 1.63) 1.10 (0.93; 1.31) 1.09 (0.92; 1.30)
HOMA-IR Wheat 2.44 (2.20; 2.69) 2.35 (2.11; 2.61) 2.23 (2.00; 2.48) 1.11 (1.00; 1.23) 1.06 (0.95; 1.18) 0.054 0.305
Rye 2.21 (2.01; 2,44) 1.97 (1.78; 2.18) 1.96 (1.77; 2.18)
Significance level is p > 0.05, significant p-values are marked in bold font. n: rye ¼ 108, wheat ¼ 99. Abbreviations: BP, blood pressure;; CRP, C-reactive protein; HOMA-IR,
homeostatic model assessment insulin resistance.
a LSMEANS, not adjusted for baseline or weight loss.
b Derived from model adjusted for baseline and change in bodyweight (week 0e12), rye group is reference for confidence intervals.
c Values above 10.00 mg/L has been omitted.
d Back transformed from natural logarithm scale.
K.N. Iversen, F. Carlsson, A. Andersson et al. Clinical Nutrition ESPEN xxx (xxxx) xxxr ¼ 0.12, p ¼ 0.08) and CRP (Week 6: r ¼ 0.06, p ¼ 0.36. Week 12:
r ¼ 0.12, p ¼ 0.09) and the analyses were adjusted for change in
body weight.
There were no differences between the groups for remaining
clinical markers (Table 8). ITT analyses of clinical markers did not
change the conclusions (Supplemental Tables 3e6).113.5. Appetite
Figure 3 and Supplemental Fig. 2 shows the appetite response
during the appetite assessments conducted at week 0, week 6 and
week 12. There were no differences between the groups in week
0 and week 12. At week 6, the rye group reported lower desire to
K.N. Iversen, F. Carlsson, A. Andersson et al. Clinical Nutrition ESPEN xxx (xxxx) xxxeat, lower hunger and higher sensation of fullness, compared to the
wheat group during the morning period. Over the rest of the day,
and over the entire day, there were no differences between the
groups at week 6.
4. Discussion
In this study we demonstrated that a hypocaloric diet rich in
high fiber rye products providing approximately 30 g rye fiber/day
lead to lower bodyweight, compared to refinedwheat, during a 12-
week dietary intervention study. We found that the weight
reduction was primarily caused by loss in body fat mass. Addi-
tionally, we found reductions in low-grade inflammation in the rye
group and indications of increased LDL cholesterol in the wheat
group. The hypothesis that increased weight loss following con-
sumption of rye products could be linked to improvements in
appetite could not be confirmed in the present study, possibly due
to methodological issues as discussed below.
This is one of the first studies investigating the effect of high-
fiber rye products on body weight reduction in the context of a
hypocaloric diet. Previous studies investigating the effect of whole
grain rye products on body weight have not been conducted in the
context of a hypocaloric diet, rather they have been ad libitum diets
where the aim was to maintain a stable body weight [10,36]. Our
analysis of body composition showed that theweight loss consisted
of fat, while the lean mass remained stable. High fat mass has
consistently been associated with increased disease risk and
reducing fat mass is generally considered to improve the health
status in overweight and obesity [37e39]. In some cases reductions
in fat mass have been shown to be a greater predictor of im-
provements in health parameters than reductions in body weight,
why reduction in fat mass during a weight loss is especially
important [37e39]. Reductions in lean mass are generally consid-
ered a negative effect of weight loss and studies have shown that
lean mass is regained to a lesser extent than fat mass during a
weight regain, why it is especially important to preserve lean mass
during weight loss [40,41]. More rapid weight loss has been shownFig. 3. Appetite response at week 0, week 6 and week 12. *p <
12to be correlated with a greater proportion of the lost weight con-
sisting of lean mass and it could be that the relatively slow weight
loss pace in the present study (approx. 0.25 kg/week in the rye
group) could have aided the preservation of lean mass [42].
Increased protein intake has been suggested to increase weight loss
and preservation of lean mass [43,44]. While the protein intake
increased slightly in the wheat group, it was stable in rye group,
why the greater weight loss in the rye groups cannot be attributed
to the potential effect of protein intake.
The energy intakewas reduced approximately 100e200 kcal per
day, which is less than the 500 kcal reduction that we were aiming
for. A 100e200 kcal deficit per day corresponds to approximately a
weight loss of approx. 0.2 kg/week, which is in line with the
observed weight loss of our participants. The energy intake did not
differ between the groups during the intervention; however, the
fiber intake was substantially higher in the rye group due to the
higher fiber content of the intervention products. It has been shown
that increasing the cereal fiber intake in the diet can lead to
increased fecal energy excretion due to binding of nutrients in the
fiber matrix [45]. This could mean that while the participants in the
two groups consumed a similar amount of energy, the higher fiber
intake in the rye group reduced the energy uptake in the gastro-
intestinal tract. However, as fecal energy excretion was not
measured in the present study, this remains hypothetical.
It should be mentioned that dietary records are prone to mea-
surement error, so the direct comparison between the participants
reported energy intake and their weight reduction should be
interpreted with care [46]. Satiety-inducing food products have
been shown to correlate with body weight reduction and improved
body weight management [17,47] and based on previous studies
showing improved satiety response following consumption of rye-
based products, compared to wheat-products, the difference in
weight loss may also be explained by increased satiety and thereby
decreased food intake in the rye group leading to an increased
weight loss. However, other studies have indicated that differences
in subjective appetite cannot be directly translated into difference
in food intake [48].0.05, **p < 0.01. Data is mean and 95% confidence interval.
K.N. Iversen, F. Carlsson, A. Andersson et al. Clinical Nutrition ESPEN xxx (xxxx) xxxPrevious studies have consistently shown a positive effect of rye
products vs refined wheat control products on appetite response
and validated by subsequent differences in ad libitum energy in-
takes [12e16]. However, these studies have been conducted in a
clinical setting, where participants conducted most of the assess-
ment in a research clinic under controlled conditions. Our present
study is one of the first studies to conduct appetite assessment at
home, in a completely free-living setting and over the course of a
whole day and evening. This means that participants have likely
been exposed to more outside stimuli, such as seeing or smelling
foods not included in the study, talking about food with colleagues
and family, and similar things that participants in clinical settings
are isolated from. While this has likely led to more variation or
“noise” in the data, it has also allowed us to evaluate the appetite
response under more realistic, real-life conditions. However, it is
important to remember that appetite responses obtained under
clinical conditions, where participants are isolated from many
stimuli that they would encounter in everyday life cannot neces-
sarily be directly transferred to real-life conditions, and extrapo-
lation of results should therefore be done with caution.
Low-grade inflammation was considerably lower in the rye
group than in the refined wheat group, even after adjustment for
change in body weight. This is line with finding from other studies
showing reduced concentration of inflammatorymarkers following
interventions with high cereal fiber intake, including whole grain
rye [20,49e51]. However, low grade inflammation is associated
with overweight and weight loss and the larger weight loss in the
rye groupmay partially explain the reduction in inflammation [52],
but other studies where subjects remained weight stable showed
positive effects of rye, indicating and independent effect of rye
[20,49]. LDL cholesterol increased in the wheat group, indicating an
adverse effect of the wheat products. Generally, rye, and whole
grain in general, have been shown to have a positive influence on
LDL cholesterol [19,20] and weight loss is also associated with re-
ductions in LDL cholesterol [53]. Based on this, we expected a dif-
ference between the groups to arise from a reduction in LDL
cholesterol in one/both intervention groups, rather than an in-
crease. It can be speculated that the increase is due to the fact that
the study was conducted in a population with habitually high
intake of whole grains [54] and the effect on LDL cholesterol is an
effect of removing these whole grains from the diet of the partici-
pants in the wheat group.
A limitation of this study, as well as many other dietary inter-
vention studies, is the lack of blinding [55]. The dieticians followed
a standardized procedure when instructing the participants and
had the initial meeting with the participants before randomization,
furthermore the outcome assessors were blinded. However, it
cannot be ruled out the participants awareness of their allocation
may have affected their behavior during the study. The baseline
sample collection was done after the 2-week run-in period and
does not necessarily reflect the participants status before the
intervention. Pre-run-in measurement of AR would have allowed
us to substantiate our discussion regarding the participants
habitual whole grain intake. The study duration is among the
longest, compared to other studies of its kind [10,36], however
long-termweight loss andweightmaintenance is amajor challenge
in the treatment of overweight and obesity and further studies on
the long-term effects is needed to draw conclusions. Nonetheless,
weight loss over a 12-week period has been shown to predict long-
term weight loss [56,57]. Furthermore, the dietary intervention
induced in this study has the potential to be implemented in par-
ticipants diet on a more permanent basis, for both weight loss and13weight maintenance, as opposed to other weight loss strategies,
such as very low calorie diets and pharmaceutical interventions,
that is not always feasible in a long term perspective [58e60].
In conclusion, this study shows that replacing refined wheat
products with high fiber rye products providing approximately 30 g
fiber/day in the context of a hypocaloric diet induces a higher body
weight and body fat reduction. Furthermore, participants in the rye
group had a lower concentration of the inflammatory marker, CRP,
after 12-week of intervention, compared to the participants in the
wheat group. A link betweenweight loss and appetite responsewas
not be shown in the present study but may be due to methodo-
logical issues and warrants further investigation.
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